vs
Magnolia Oil & Gas Corp(MGY)与Ultragenyx Pharmaceutical Inc.(RARE)财务数据对比。点击上方公司名可切换其他公司
Magnolia Oil & Gas Corp的季度营收约是Ultragenyx Pharmaceutical Inc.的1.5倍($317.6M vs $207.3M),Magnolia Oil & Gas Corp净利率更高(21.6% vs -62.0%,领先83.7%),Ultragenyx Pharmaceutical Inc.同比增速更快(25.9% vs -2.7%),过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高(38.0% vs -0.3%)
帝国石油是加拿大第二大一体化石油企业,由美国石油巨头埃克森美孚持有69.6%的多数股权,有时也被称为帝国埃索。公司业务涵盖原油、稀释沥青和天然气开采,同时是加拿大主要的石油炼制商与石化产品生产商,为埃索品牌加油站提供油品供应。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业,专注于研发罕见病和超罕见遗传病的创新治疗方案,这类疾病目前大多无获批疗法,存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台,研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
MGY vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $317.6M | $207.3M |
| 净利润 | $68.8M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 29.6% | -54.7% |
| 净利率 | 21.6% | -62.0% |
| 营收同比 | -2.7% | 25.9% |
| 净利润同比 | -19.7% | 3.5% |
| 每股收益(稀释后) | — | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $317.6M | $207.3M | ||
| Q3 25 | $324.9M | $159.9M | ||
| Q2 25 | $319.0M | $166.5M | ||
| Q1 25 | $350.3M | $139.3M | ||
| Q4 24 | $326.6M | $164.6M | ||
| Q3 24 | $333.1M | $139.5M | ||
| Q2 24 | $336.7M | $147.0M | ||
| Q1 24 | $319.4M | $108.8M |
| Q4 25 | $68.8M | $-128.6M | ||
| Q3 25 | $75.5M | $-180.4M | ||
| Q2 25 | $78.1M | $-115.0M | ||
| Q1 25 | $102.9M | $-151.1M | ||
| Q4 24 | $85.6M | $-133.2M | ||
| Q3 24 | $99.8M | $-133.5M | ||
| Q2 24 | $95.6M | $-131.6M | ||
| Q1 24 | $85.1M | $-170.7M |
| Q4 25 | 29.6% | -54.7% | ||
| Q3 25 | 31.2% | -106.9% | ||
| Q2 25 | 33.8% | -64.8% | ||
| Q1 25 | 38.8% | -102.6% | ||
| Q4 24 | 38.0% | -74.3% | ||
| Q3 24 | 38.7% | -94.6% | ||
| Q2 24 | 39.9% | -79.1% | ||
| Q1 24 | 39.0% | -151.9% |
| Q4 25 | 21.6% | -62.0% | ||
| Q3 25 | 23.2% | -112.8% | ||
| Q2 25 | 24.5% | -69.0% | ||
| Q1 25 | 29.4% | -108.5% | ||
| Q4 24 | 26.2% | -80.9% | ||
| Q3 24 | 30.0% | -95.7% | ||
| Q2 24 | 28.4% | -89.5% | ||
| Q1 24 | 26.6% | -156.8% |
| Q4 25 | — | $-1.28 | ||
| Q3 25 | — | $-1.81 | ||
| Q2 25 | — | $-1.17 | ||
| Q1 25 | — | $-1.57 | ||
| Q4 24 | — | $-1.34 | ||
| Q3 24 | — | $-1.40 | ||
| Q2 24 | — | $-1.52 | ||
| Q1 24 | — | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $266.8M | $421.0M |
| 总债务越低越好 | $393.3M | — |
| 股东权益账面价值 | $2.0B | $-80.0M |
| 总资产 | $2.9B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.20× | — |
8季度趋势,按日历期对齐
| Q4 25 | $266.8M | $421.0M | ||
| Q3 25 | $280.5M | $202.5M | ||
| Q2 25 | $251.8M | $176.3M | ||
| Q1 25 | $247.6M | $127.1M | ||
| Q4 24 | $260.0M | $174.0M | ||
| Q3 24 | $276.1M | $150.6M | ||
| Q2 24 | $275.7M | $480.7M | ||
| Q1 24 | $399.3M | $112.3M |
| Q4 25 | $393.3M | — | ||
| Q3 25 | $393.1M | — | ||
| Q2 25 | $392.9M | — | ||
| Q1 25 | $392.7M | — | ||
| Q4 24 | $392.5M | — | ||
| Q3 24 | $394.8M | — | ||
| Q2 24 | $394.1M | — | ||
| Q1 24 | $393.5M | — |
| Q4 25 | $2.0B | $-80.0M | ||
| Q3 25 | $2.0B | $9.2M | ||
| Q2 25 | $2.0B | $151.3M | ||
| Q1 25 | $2.0B | $144.2M | ||
| Q4 24 | $2.0B | $255.0M | ||
| Q3 24 | $2.0B | $346.8M | ||
| Q2 24 | $1.9B | $432.4M | ||
| Q1 24 | $1.9B | $140.3M |
| Q4 25 | $2.9B | $1.5B | ||
| Q3 25 | $2.9B | $1.2B | ||
| Q2 25 | $2.9B | $1.3B | ||
| Q1 25 | $2.9B | $1.3B | ||
| Q4 24 | $2.8B | $1.5B | ||
| Q3 24 | $2.8B | $1.5B | ||
| Q2 24 | $2.8B | $1.6B | ||
| Q1 24 | $2.8B | $1.3B |
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.21× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $208.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 3.03× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势,按日历期对齐
| Q4 25 | $208.4M | $-99.8M | ||
| Q3 25 | $247.1M | $-91.4M | ||
| Q2 25 | $198.7M | $-108.3M | ||
| Q1 25 | $224.5M | $-166.5M | ||
| Q4 24 | $222.6M | $-79.3M | ||
| Q3 24 | $217.9M | $-67.0M | ||
| Q2 24 | $269.4M | $-77.0M | ||
| Q1 24 | $210.9M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | — | $-167.8M | ||
| Q4 24 | — | $-79.5M | ||
| Q3 24 | — | $-68.6M | ||
| Q2 24 | — | $-79.0M | ||
| Q1 24 | — | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | — | -120.5% | ||
| Q4 24 | — | -48.3% | ||
| Q3 24 | — | -49.2% | ||
| Q2 24 | — | -53.7% | ||
| Q1 24 | — | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.4% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 3.03× | — | ||
| Q3 25 | 3.27× | — | ||
| Q2 25 | 2.54× | — | ||
| Q1 25 | 2.18× | — | ||
| Q4 24 | 2.60× | — | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.82× | — | ||
| Q1 24 | 2.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGY
| Oil And Condensate | $215.6M | 68% |
| Natural Gas Reserves | $52.9M | 17% |
| Natural Gas Liquids Reserves | $49.1M | 15% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |